Sukla C.

Sukla C. possesses extensive experience in molecular biology and assay development, with a career spanning over two decades across various prestigious organizations. Key roles include serving as a Senior Scientist in Cancer Vaccine and Immunotherapeutics at Pfizer, where responsibilities include leading molecular assays for cancer vaccine projects, and previously as a Consultant/Contractor at EntroGen, Inc. focusing on the design and development of multiplex qPCR assays for cancer mutation detection. Contributions at companies such as Trovagene, Cell Genesys, and Agilent Technologies highlight expertise in developing genomic assays and investigating cancer-specific mutations using advanced techniques like NGS and qPCR. Academic foundations include a Ph.D. in Molecular and Cellular Biology from the University of Alabama at Birmingham, reinforced by influential research positions, notably leading investigations at the Sidney Kimmel Cancer Center.